hemogenyx

18 days ago

Tom Winnifrith Bearcast No2: what's the difference between Hemogenyx and syphilis?

One is a disgusting disease and the other is a STI. Boom. Boom. I start with the latter and end with the former. In between I look in detail at the ludicrous AIM IPO of SundaeBar (SBAR) ,a £41m disgrace from Roland "Fatty" Cornish and the Bixby/Edwards gang, at MJ Gleeson (GLE) and the wider housebuilding sector and at First Class Metals (FCM) as it rapidly runs out of cash obtained from the proceeds of crime.
---

38 days ago

Tom Winnifrith Bearcast: I am now over 10%, keep pledging

In today’s bearcast I look at Optibiotix (OPTI), the standing of the London markets and the prospectus exemption scandal that needs addressing to stop rogues like Hemogenyx (HEMO), Genflow (GENF) and Predator Oil & Gas (PRD) duping shareholders. I am writing to the FCA about this matter this weekend. 

---

41 days ago

Genflow: here we go again, how does the FCA tolerate this shit?

If you are on the main market after you have issued a certain number of shares you need the FCA to sign off on a prospectus to be allowed to issue more and get them admitted to trading. But there is an exception that allows management to subscribe for new shares. That is fine. But this exception is being utterly abused by the scumbags at the bottom end of the market. Yesterday, with an RNS that was clearly fiction it was Hemogenyx (HEMO). Today it is Genflow Biosciences (GENF), a company created by penny share fraudster Ron Bauer and his known associate Adrian Beeston.

---

41 days ago

Hemogenyx Pharmaceuticals placing just stinks, there will be no TR1

It was running on vapours so it’s no shock that Hemogenyx (HEMO), the pointless main market listed lifestyle company run by pompous prick Vlad Sandler has placed yet again, raising £451,000 gross at 180.5p. That will keep the wolf from the door for a couple of months by when Vlad will have to do another funding. But this one stinks, the RNS looks like its a lie.

---

50 days ago

Tom Winnifrith Bearcast: I realise there is intense competition but is this the FT's worst prediction ever?

I start with yesterday's elections including a dig at the wretched FT. The fickle sentiment Optibiotix (OPYI) and a company I do not write about failing to issue an RNs as they should, Hemogenyx (HEMO), Mirriad (MIRI) and Amigo (AMGO), all three of which should be toast.

---

53 days ago

Tom Winnifrith Bearcast No 2: Profit is a matter of opinion

In today's bearcast I look at Celadon (CEL), Hemogenyx (HEMO), with a plea to Peterhouse to do the right 'ffing thing, Anexo (ANX), Manolete (MANO) and Sam Antar

---

53 days ago

Evil Banksta: Hemogenyx must be almost bust, finals stink

I have been a perma bear of Hemogenyx (HEMO) flagging up pig and pork fund raisings, outrageous claims of progress that cannot be justified, executive greed and more. But for some reason I missed yesterday’s calendar 2024 results. Luckily Liverpool’s greatest numbers man since Ken Dodd is on the case and flags up what a total horror show this is. Evil Banksta opines:

---

78 days ago

Are you talking about me Frances or the Hemogenyx boss?

Frances Farmer uses the sort of language that would make the late Bernard Manning blush over on X, formerly twitter. I have no idea who Frances is but he/she/they have launched a mini tirade against either myself or the arsehole boss of Hemogenyx (HEMO), Vlad Sandler.
---

96 days ago

Hemogenyx – Vlad Sandler, Peter Redmond (aged 194) et al, this is just so unethical

Once again, I brace myself to be accused of batting for team leukemia for having the nerve to point out bad things at Hemogenyx (HEMO). The reality is that it is Hemogenyx and its boss, Vlad Sandler, on £400,000+ a year, who are acting in an unethical way.
---

102 days ago

Hemogenyx – Vlad Sandler takes the piss again with another discounted placing

Vlad earned £397,000 in 2023 so with employers taxes and expenses will have cost Hemogenyx (HEMO) close to half a Bernie. The two NEDS, Alex Sander and 196 year old Peter Redmond earned a combined £110,000 so will have cost at least £150,000 so the PLC costs of running this crock will be close to a Bernie. Not that it has actually made much progress in the labs.
---

113 days ago

Tom Winnifrith Bearcast No 1: 8 years of red flags at Hemogenyx

In the end this will be a zero. I go back to the first days on the London market of Hemogenyx (HEMO). the red flags were there from day one eight years ago. Anyone holding is nutso.

---

115 days ago

Does the Hemogenyx CEO work for free? Au Contraire: Pompous Twit on twitter pokes a bear

I awake to find another tweet directed my way regarding Hemogenyx (HEMO), the unethical stock promote that will not cure cancer but says it might to promote its shares. This time it is not a shareholder accusing me of backing cancer but the CEO, Vlad Sandler who is tweeting. Vlad is pompous and seems to want to annoy me. He has and so I have done more digging!
---

185 days ago

Hemogenyx and that share consolidation to attract institutional investors: how’s it going?

Since exposing its pig and pork scam a few months ago HERE, Hemogenyx (HEMO) has been very much on my radar. It is a classic biotech promote which could not cure ham let alone any disease. Even at today’s 320p, a market cap of c£11 million is a gross overvaluation of a company that will be gigging with the Fat Lady within weeks if it cannot place and which, after years of spoofing, has made SFA clinical progress.

---

203 days ago

Hemogenyx: When folks invoke and celebrate my mother’s suicide you know they have lost the argument

It is rather like folks who bring in Hitler to a debate. It is the moment that you know they have not only lost the argument but in this case also their moral compass. I have never hidden the fact that when I was eight my mother killed herself.

---

203 days ago

Hemogenyx owning moron JohnR thinks Tom Winnifrith is a “scumbag” and "disgrace"battlng for team leukemia

https://shareprophets.com/views/77756/hemogenyx-owning-moron-johnr-thinks-tom-winnifrith-is-a-scumbag-and-disgrace-battlng-for-team-leukemia

---

203 days ago

Hemogenyx is a short – target 0p

Yes: you can get borrow. Tim Kempster is short and you should join him at 1.2p, my target for Hemogenyx (HEMO) is 0p. Here is why.

---

203 days ago

Tom Winnifrith Bearcast: one month to Christmas

Starting with the festive note I look at Kingfisher (KGF), Hemogenyx (HEMO), Georgina Energy (GEX), Powerhouse Energy (PHE), ECR Minerals (ECR) and BWA (BWAF)

---

203 days ago

Tim Kempster warns those foolish enough to own Hemogenyx

I have warned folks repeatedly about this dog. I think that short seller Tim Kempster is actually being rather too generous with his assessment of Hemogenyx (HEMO). As folks start to panic…

---

209 days ago

Tom Winnifrith Bearcast: Hemogenyx you guys are taking the piss!

https://shareprophets.com/views/77682/tom-winnifrith-bearcast-hemogenyx-you-guys-are-taking-the-piss

---

2658 days ago

Tom Winnifrith Bearcast: The AIM CEO who appears guilty of mortgage fraud

I am not at this point naming him or the Nomad (individual and firm) or the NED who turned a blind eye. But this is, as they say, developing. Elsewhere ahead of a visit to the dentist I discuss the joys of reading my Dad's Guardian, Frontera Resources (FRR), Realm Therapeutics (RLM), Hemogenyx (HEMO), and Draganfly (DRG).

---

2672 days ago

Hemogenyx shares soar 117% after two tweets - is this the new RNS? Surely this is a bit naughty

Is @HemoGenyx the corporate account of HemoGenyx (HEMO)? Sadly PR poltroon Paul "Queenie" McManus of Walbrook and pouting brokerette Lucy Williams of Peterhouse have yet to return my calls as I pose this question. But since the lamentable Walbrook has tweeted directed to @HemoGenyx in the past they are either complete idiots (well they are) or that is all the confirmation one needs. Which makes the last two tweets on this account all the more outrageous. You can see them below. Bear in mind there has been no supporting RNS.

---
Sign up for my weekly newsletter








Required Reading

Recent Comments
I also read